Brief: Australian Clinical Labs Announces On Market Share Buy Back
Oct 23 (Reuters) - Australian Clinical Labs Ltd ACL.AX: ON MARKET SHARE BUY BACK OF UP TO 19.5 MILLION ACL SHARES Further company coverage: ACL.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Australian Clinical Labs
See all newsBrief: Australian Clinical Labs Appoints Deloitte As Auditor
Australia's Optiscan rises after imaging more than 80 cases in ACL study
Australian Clinical Labs falls to over two-week low on trading ex-dividend
Australian Clinical Labs at 6-month high on upbeat full-year results, guidance
Brief: Australian Clinical Labs Says It Expects FY27 Revenue Of A$745-765 Million